Mar 14, 2023 / 05:20PM GMT
Jay Olson - Oppenheimer & Co. Inc., Research Division - Executive Director & Senior Analyst
Hello, everyone, and welcome to Oppenheimer's 33rd Annual Healthcare Conference. I'm Jay Olson, one of the biotechnology analysts at Oppenheimer. And I want to thank you all for joining us here today.
It's my pleasure to welcome Exelixis to our conference. And it's an honor to introduce Michael Morrissey, President and CEO. Thank you, Michael, so much for joining us here today.
Michael M. Morrissey - Exelixis, Inc. - CEO, President & Director
Jay, it's great to be here. Sorry, we're not doing this live. I guess there's weather on both coasts today. So maybe this is probably the most expedient way to be able to chat. So yes, it's great to be here.
Before we begin, let me just mention that I'll be making forward-looking statements today. So please see our SEC filings for a description of the risks that we face in our business.
Jay Olson - Oppenheimer & Co. Inc., Research Division - Executive Director &
Exelixis Inc at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 14, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers